Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)

Peer Review reports

Original Submission
17 Jul 2019	Submitted	Original manuscript
6 Sep 2019	Reviewed	Reviewer Report - Kirsty Loudon
7 Oct 2019	Author responded	Author comments - Danni Li
Resubmission - Version 2
7 Oct 2019	Submitted	Manuscript version 2
Publishing
11 Oct 2019	Editorially accepted
6 Jan 2020	Article published	10.1186/s13063-019-3798-1

Back to article page